Ultragenyx Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
27.02.24
/
50%
€49.60
Target price
27.02.25
€81.12
Performance (%)
-17.74%
End price
28.02.25
€40.80
Summary
This prediction ended on 28.02.25 with a price of €40.80. The prediction for Ultragenyx Pharmaceutical Inc. disappointed with a performance of -17.74%. JPMorgan_Chase___Co_ has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -5.376% | -5.376% | -51.913% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at JPMorgan Chase & Co. from $84.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
27.03.25
27.03.25
€108.68
27.03.26
27.03.26
-51.11%
20.03.26
20.03.26
Stopped prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€19.10
12.03.26
12.03.26
€64.16
12.03.27
12.03.27
-6.28%
20.03.26
20.03.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€44.00
21.11.24
21.11.24
€96.83
21.11.25
21.11.25
-34.09%
22.11.25
22.11.25